SCHEMBL292111

SCHEMBL292111

CC(C)(C)c1cc(O)c(Cc2ccc(O)cc2)c(C(C)(C)C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.42
TYR P14679 2/20 0.42
ALDH1A1 P00352 2/20 0.42
ALOX15 P16050 2/20 0.42
HSD17B10 Q99714 2/20 0.42
CYP2C9 P11712 2/20 0.42
NR1I2 O75469 1/20 0.42
MIF P14174 1/20 0.42
HTT P42858 1/20 0.42
NFE2L2 Q16236 1/20 0.42
ESR1 P03372 5/20 0.41
ESR2 Q92731 3/20 0.41
HPGD P15428 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
GABRA1 P14867 1/20 0.38
GABRB2 P47870 1/20 0.38
SLC28A3 Q9HAS3 1/20 0.38
ESRRG P62508 3/20 0.37
ESRRB O95718 2/20 0.36
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11681295 0.87 TSHR (0.46) ALDH1A1ALOX15HSD17B10CYP2C9HPGD
SCHEMBL11087884 0.87 THRA (0.44) LMNATYRALDH1A1ALOX15HSD17B10
SCHEMBL6299373 0.84 ALDH1A1 (0.44) LMNATYRALDH1A1ALOX15HSD17B10
SCHEMBL9007185 0.81 LMNA (0.48) LMNATYRALDH1A1ALOX15HSD17B10
SCHEMBL8772279 0.78 HSPA5 (0.49) LMNATYRALDH1A1ALOX15HSD17B10
SCHEMBL9106331 0.75 ESR1 (0.56) LMNATYRHSD17B10ESR1ESR2
SCHEMBL27877809 0.75 ALDH1A1 (0.43) LMNATYRALDH1A1ALOX15HSD17B10
SCHEMBL3616927 0.75 ALDH1A1 (0.39) LMNATYRALDH1A1ALOX15HSD17B10
SCHEMBL1159884 0.74 ALDH1A1 (0.41) LMNATYRALDH1A1ALOX15HSD17B10
SCHEMBL29022939 0.74 CA2 (0.48) LMNATYRALDH1A1ALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10016501-B2 Cationic antiseptic compositions and methods of use 3M INNOVATIVE PROPERTIES COMPANY (US) 2018-07-10 US claimed
US-20150231248-A1 CATIONIC ANTISEPTIC COMPOSITIONS AND METHODS OF USE 3M INNOVATIVE PROPERTIES COMPANY 2015-08-20 US claimed
US-11925733-B2 Malodor counteractant composition and methods BELL FLAVORS & FRAGRANCES, INC. (US) 2024-03-12 US disclosed
EP-3541355-B1 MALODOR COUNTERACTANT COMPOSITION AND METHODS BELL FLAVORS AND FRAGRANCES INC (US) 2023-06-07 EP disclosed
US-20220110906-A1 ANTIMICROBIAL DENTAL APPLIANCE 3M INNOVATIVE PROPERTIES COMPANY 2022-04-14 US disclosed
US-20210353814-A1 MALODOR COUNTERACTANT COMPOSITION AND METHODS BELL FLAVORS & FRAGRANCES, INC. (US) 2021-11-18 US disclosed
EP-3905985-A1 ANTIMICROBIAL DENTAL APPLIANCE 3M Innovative Properties Company (US) 2021-11-10 EP disclosed
CN-113260333-A Antimicrobial dental appliance 3M创新有限公司 2021-08-13 CN disclosed
EP-3501488-B1 AQUEOUS SILICONE POLYMER COMPOSITIONS MOMENTIVE PERFORMANCE MAT GMBH (DE) 2021-04-14 EP disclosed
US-10947383-B2 Aqueous silicone polymer compositions MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) 2021-03-16 US disclosed
US-20210060110-A1 ANTISEPTIC COMPOSITONS AND METHODS OF USE 3M INNOVATIVE PROPERTIES COMPANY 2021-03-04 US disclosed
US-20060051385-A1 Cationic antiseptic compositions and methods of use 3M INNOVATIVE PROPERTIES COMPANY 2006-03-09 US disclosed
US-20060052452-A1 Phenolic antiseptic compositions and methods of use 3M INNOVATIVE PROPERTIES COMPANY 2006-03-09 US disclosed
US-20060051384-A1 Antiseptic compositions and methods of use 3M INNOVATIVE PROPERTIES COMPANY 2006-03-09 US disclosed
US-20050089539-A1 Antimicrobial compositions and methods 3M INNOVATIVE PROPERTIES COMPANY 2005-04-28 US disclosed
US-20050084471-A1 Concentrated antimicrobial compositions and methods 3M INNOVATIVE PROPERTIES COMPANY 2005-04-21 US disclosed
US-20050058673-A1 Antimicrobial compositions and methods 3M INNOVATIVE PROPERTIES COMPANY 2005-03-17 US disclosed
WO-2005023023-A1 CONCENTRATED ANTIMICROBIAL COMPOSITIONS AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2005-03-17 WO disclosed
WO-2005023233-A2 ANTIMICROBIAL COMPOSITIONS AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2005-03-17 WO disclosed
US-4067997-A NONIONIC SURFACTANT ESTER, PHENOLIC MICROBIOCIDE MED-CHEM LABORATORIES (US) 1978-01-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060051385-A1 Cationic antiseptic compositions and methods of use KCNN3, DSG1, CLIC1 LMNA 2923/4885TYR 875/4885ALDH1A1 4239/4885
US-10016501-B2 Cationic antiseptic compositions and methods of use KCNN3, DSG1, CLIC1 LMNA 2923/4885TYR 875/4885ALDH1A1 4239/4885
US-20150231248-A1 CATIONIC ANTISEPTIC COMPOSITIONS AND METHODS OF USE KCNN3, DSG1, CLIC1 LMNA 2923/4885TYR 875/4885ALDH1A1 4239/4885
US-20210060110-A1 ANTISEPTIC COMPOSITONS AND METHODS OF USE C9, C1S, FABP2 LMNA 1948/4885TYR 1093/4885ALDH1A1 3288/4885
US-20050084471-A1 Concentrated antimicrobial compositions and methods SHARPIN, PIK3C3, SRM LMNA 3199/4885TYR 504/4885ALDH1A1 1797/4885
US-20060051384-A1 Antiseptic compositions and methods of use ALOX12, C9, LPO LMNA 2826/4885TYR 1102/4885ALDH1A1 2025/4885
US-20060052452-A1 Phenolic antiseptic compositions and methods of use FABP2, EBP, LCT LMNA 3023/4885TYR 19/4885ALDH1A1 2857/4885
US-20220110906-A1 ANTIMICROBIAL DENTAL APPLIANCE MGLL, LIPA, MLEC LMNA 3370/4885TYR 2449/4885ALDH1A1 4365/4885
US-20050089539-A1 Antimicrobial compositions and methods FABP2, CUTA, LIPA LMNA 2179/4885TYR 710/4885ALDH1A1 2926/4885
US-10947383-B2 Aqueous silicone polymer compositions CUTA, IL6, SHC1 LMNA 1981/4885TYR 815/4885ALDH1A1 4298/4885
US-20050058673-A1 Antimicrobial compositions and methods FABP2, CUTA, LIPA LMNA 2058/4885TYR 533/4885ALDH1A1 2348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.